Improved virus vaccines
CA 2222283 C · Owner: Wilkinson, Bethanie E. · Inventors: Volvovitz, Franklin; Hackett, Craig S.; Voznesensky, Andrei I.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Improved mammalian virus vaccines are combinations that contain an immunogenic amount of inactivated virus, such as influenza virus Herpes varicella virus, measles virus, Epstein Barr virus respiratory syncytial virus, parainfluenza 3, Herpes simplex type 1 virus, and Herpes simplex type 2 virus and an , immunogenic amount of a purified recombinant envelope protein from the virus or a fragment or precursor of the protein. Alternatively they contain either , inactivated virus and/or envelope protein antigens and an adjuvant such as granulocyte-macrophage colony stimulating factor. One embodiment of an influenza vaccine is prepared by combining inactivated virus preferably three , strains …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 26, 1996 and granted February 3, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 26, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 26, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.